Skip to main content

Find Clinical Trials

Home
Conditions
Immunologic Deficiency Syndromes

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,128 public trials 394 recruiting studies

Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients

NCT00466180

Conditions: Behavior, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School Students

NCT00167505

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations: University of Texas Houston School of Public Health Houston, Texas, United States

View Trial Details

Completed

Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

NCT00132210

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations: Practice Hintsche Berlin, Germany

Practice Bieniek Berlin, Germany

Practice Dupke/Carganico/Baumgarten Berlin, Germany

Practice Schranz Berlin, Germany

View all 14 locations

View Trial Details

Completed

A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

NCT00659191

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: GSK Investigational Site Fort Lauderdale, Florida, United States

GSK Investigational Site Fort Lauderdale, Florida, United States

GSK Investigational Site Orlando, Florida, United States

GSK Investigational Site Charlotte, North Carolina, United States

View Trial Details

Completed

Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects

NCT00112047

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: AIDS Healthcare Foundation Research Beverly Hills, California, United States

Capital Medical Associates, P.C. Washington D.C., District of Columbia, United States

Orlando Immunology Center Orlando, Florida, United States

NorthStar Medical Center Chicago, Illinois, United States

View Trial Details

Completed

A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring

NCT01144676

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: SGS Life Science Services Antwerp, Flanders, Belgium

View Trial Details

Completed

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

NCT00071890

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

Hospital Henri Mondor Créteil, France

View Trial Details

Completed

SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

NCT00225082

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +19 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

NCT00053638

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Fountain Valley, California, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site San Francisco, California, United States

View all 58 locations

View Trial Details

Completed

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

NCT00094367

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: GSK Investigational Site Montgomery, Alabama, United States

GSK Investigational Site Glendale, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 178 locations

View Trial Details